Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1971 1
1972 4
1973 1
1975 2
1976 1
1977 2
1978 3
1979 2
1980 3
1981 3
1982 3
1983 1
1984 2
1985 3
1986 3
1987 2
1989 1
1990 1
1991 1
1992 2
1993 1
1994 2
1995 2
1996 1
1998 1
2000 1
2001 4
2002 2
2003 2
2004 2
2005 2
2006 3
2007 6
2008 1
2009 2
2010 4
2011 5
2012 5
2013 1
2014 4
2015 3
2016 5
2017 6
2018 1
2019 6
2020 14
2021 11
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
Down syndrome and Alzheimer's disease: Common pathways, common goals.
Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K, Krams M, Lemere C, Lott I, Mobley W, Ness S, Nixon R, Potter H, Reeves R, Sabbagh M, Silverman W, Tycko B, Whitten M, Wisniewski T. Hartley D, et al. Among authors: lott i. Alzheimers Dement. 2015 Jun;11(6):700-9. doi: 10.1016/j.jalz.2014.10.007. Epub 2014 Dec 12. Alzheimers Dement. 2015. PMID: 25510383 Free PMC article.
Antioxidants in Down syndrome.
Lott IT. Lott IT. Biochim Biophys Acta. 2012 May;1822(5):657-63. doi: 10.1016/j.bbadis.2011.12.010. Epub 2011 Dec 21. Biochim Biophys Acta. 2012. PMID: 22206998 Free PMC article. Review.
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology.
Handen BL, Lott IT, Christian BT, Schupf N, OBryant S, Mapstone M, Fagan AM, Lee JH, Tudorascu D, Wang MC, Head E, Klunk W, Ances B, Lai F, Zaman S, Krinsky-McHale S, Brickman AM, Rosas HD, Cohen A, Andrews H, Hartley S, Silverman W; Alzheimer's Biomarker Consortium‐Down Syndrome (ABC‐DS). Handen BL, et al. Among authors: lott it. Alzheimers Dement (Amst). 2020 Aug 3;12(1):e12065. doi: 10.1002/dad2.12065. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32775597 Free PMC article. Review.
Neuropathological correlates of amyloid PET imaging in Down syndrome.
Abrahamson EE, Head E, Lott IT, Handen BL, Mufson EJ, Christian BT, Klunk WE, Ikonomovic MD. Abrahamson EE, et al. Among authors: lott it. Dev Neurobiol. 2019 Jul;79(7):750-766. doi: 10.1002/dneu.22713. Epub 2019 Aug 17. Dev Neurobiol. 2019. PMID: 31379087 Free PMC article. Review.
Alzheimer-Related Cerebrovascular Disease in Down Syndrome.
Lao PJ, Gutierrez J, Keator D, Rizvi B, Banerjee A, Igwe KC, Laing KK, Sathishkumar M, Moni F, Andrews H, Krinsky-McHale S, Head E, Lee JH, Lai F, Yassa MA, Rosas HD, Silverman W, Lott IT, Schupf N, Brickman AM. Lao PJ, et al. Among authors: lott it. Ann Neurol. 2020 Dec;88(6):1165-1177. doi: 10.1002/ana.25905. Epub 2020 Oct 9. Ann Neurol. 2020. PMID: 32944999 Free PMC article.
Down syndrome: from understanding the neurobiology to therapy.
Gardiner K, Herault Y, Lott IT, Antonarakis SE, Reeves RH, Dierssen M. Gardiner K, et al. Among authors: lott it. J Neurosci. 2010 Nov 10;30(45):14943-5. doi: 10.1523/JNEUROSCI.3728-10.2010. J Neurosci. 2010. PMID: 21068296 Free PMC article. Review.
Beta-amyloid, oxidative stress and down syndrome.
Lott IT, Head E, Doran E, Busciglio J. Lott IT, et al. Curr Alzheimer Res. 2006 Dec;3(5):521-8. doi: 10.2174/156720506779025305. Curr Alzheimer Res. 2006. PMID: 17168651 Review.
Down syndrome and beta-amyloid deposition.
Head E, Lott IT. Head E, et al. Among authors: lott it. Curr Opin Neurol. 2004 Apr;17(2):95-100. doi: 10.1097/00019052-200404000-00003. Curr Opin Neurol. 2004. PMID: 15021233 Review.
133 results